¼¼°èÀÇ ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : À¯Çüº°, ±â¼úº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð ¹× Á¡À¯À², ¿¹Ãø(2025-2032³â)
Glucometer Market, By Type, By Technology, By Distribution Channel, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1629211
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 398 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,612,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,598,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,017,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

±Û·çÄÚ¹ÌÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 164¾ï 3,512¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2032³â¿¡ CAGR 12.8%·Î È®´ë

Ç÷´ç ÃøÁ¤±â ½ÃÀå ¿ªÇÐ

½Ç½Ã°£ Æ÷µµ´ç ÃßÀû ÅëÇÕÀ» À§ÇÑ ¸ð¹ÙÀÏ ¾Û äÅà Áõ°¡.

½Ç½Ã°£ Ç÷´ç ÃßÀûÀ» À§ÇÑ ¸ð¹ÙÀÏ ¾ÛÀÇ Ã¤Åà Áõ°¡´Â Ç÷´ç ÃøÁ¤±â ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ½º¸¶Æ®Æù°ú ¿þ¾î·¯ºí ±â¼úÀÌ ´ëÁßÈ­µÊ¿¡ µû¶ó ¸¹Àº »ç¿ëÀÚµéÀÌ ¸ð¹ÙÀÏ ¾Û°ú ¿øÈ°ÇÏ°Ô ÅëÇÕµÈ Ç÷´çÃøÁ¤±â¸¦ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ¸¦ ÅëÇØ »ç¿ëÀÚ´Â Ç÷´ç ¼öÄ¡¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇϰí, Ãß¼¼¸¦ ÃßÀûÇϰí, ´ç´¢º´À» ´õ Àß °ü¸®Çϱâ À§ÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿Í µ¥ÀÌÅ͸¦ °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº Áï°¢ÀûÀÎ Çǵå¹éÀ» Á¦°øÇÏ°í °³ÀÎÀÌ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á »ç¿ëÀÚ °æÇèÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç÷´ç µ¥ÀÌÅ͸¦ ¸ð¹ÙÀÏ ±â±â¿¡ ÀúÀåÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ´Â ÆíÀǼºÀº È¿°úÀûÀÎ ´ç´¢º´ °ü¸®¿¡ ÇʼöÀûÀÎ º¸´Ù ÀϰüµÈ ¸ð´ÏÅ͸µÀ» ÃËÁøÇÕ´Ï´Ù. µðÁöÅÐ ÀÇ·á ¼Ö·ç¼Ç Áõ°¡´Â ¼ÒºñÀÚµéÀÌ Áý¿¡¼­ ½±°Ô ÀÚ½ÅÀÇ »óŸ¦ °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ¸ð¹ÙÀÏ ¾Û°ú ȣȯµÇ´Â Ç÷´çÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

Ç÷´ç ÃøÁ¤±â ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÌ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¾à 12.8% ¿¬Æò±Õ ¾à 12.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

À¯Çüº°·Î´Â Ç÷´ç ÃøÁ¤±â°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼úº°·Î´Â 2024³â ½ºÆ®¸³Çü Ç÷´çÃøÁ¤±â°¡ ÁÖ¿ä ±â¼úÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ÁÖ¿ä ¼öÀÔ¿øÀÌ µÉ °ÍÀÔ´Ï´Ù.

Ç÷´ç ÃøÁ¤±â ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°è Ç÷´ç ÃøÁ¤±â ½ÃÀåÀº À¯Çü, ±â¼ú, À¯Åë ä³Î, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó Ç÷´ç ÃøÁ¤±â, ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛ, Ç÷´ç ÃøÁ¤±â µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Ç÷´ç ÃøÁ¤±â ºÎ¹®Àº Ç÷´ç ÃøÁ¤±â ½ÃÀå¿¡¼­ °¡Àå µÎµå·¯Áý´Ï´Ù. ÀÌ Á¦Ç° À¯ÇüÀº Àú·ÅÇÑ °¡°Ý, »ç¿ë ÆíÀǼº, Á¢±Ù¼ºÀ» Á¦°øÇÏ¸ç ¼ö³â µ¿¾È ³Î¸® »ç¿ëµÇ¾î ¿Ô½À´Ï´Ù. Ç÷´ç ÃøÁ¤±â´Â »ç¿ëÀÚ°¡ ÃÖ¼ÒÇÑÀÇ ±â¼úÀû º¹À⼺À¸·Î ½±°Ô Ç÷´ç ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö Àִ ȨÄɾî ȯ°æ¿¡¼­ ƯÈ÷ ÀαⰡ ³ô½À´Ï´Ù. ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛÀÇ ¼ºÀå¿¡µµ ºÒ±¸Çϰí Ç÷´ç ÃøÁ¤±â´Â Àú·ÅÇÑ ºñ¿ë, °£´ÜÇÑ Á¶ÀÛ ¹× ´ç´¢º´À» °ü¸®ÇÏ´Â °³ÀÎµé »çÀÌ¿¡¼­ ³Î¸® ¹Þ¾Æµé¿©Áö°í ÀÖÀ¸¹Ç·Î ¿©ÀüÈ÷ Áö¹èÀûÀÔ´Ï´Ù. ÀÌ ºÎ¹®Àº ƯÈ÷ °¡°Ý¿¡ ¹Î°¨ÇÑ Àα¸°¡ ¸¹Àº Áö¿ª¿¡¼­ °è¼Ó ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ±â¼ú¿¡ µû¶ó ½ºÆ®¸³Çü Ç÷´ç ÃøÁ¤±â¿Í ºñħ½ÀÀû Ç÷´ç ÃøÁ¤±âÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ±â¼úº°·Î´Â ½ºÆ®¸³Çü Ç÷´çÃøÁ¤±â°¡ °¡Àå µÎµå·¯Áý´Ï´Ù. ÀÌ ±â¼úÀº Æí¸®ÇÔ°ú Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÎÇØ Æ÷µµ´ç ¸ð´ÏÅ͸µ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Ç÷¾× »ùÇðú ¹ÝÀÀÇÏ´Â Å×½ºÆ® ½ºÆ®¸³À» »ç¿ëÇÏ¿© ÀÛµ¿ÇÏ¿© Æ÷µµ´ç ¼öÄ¡ ÆÇµ¶°ªÀ» Á¦°øÇÕ´Ï´Ù. ½ºÆ®¸³Çü Ç÷´çÃøÁ¤±â´Â ´Ù¸¥ ±â¼ú¿¡ ºñÇØ »ç¿ë ÆíÀǼº, ºü¸¥ °á°ú, Àú·ÅÇÑ ºñ¿ëÀ¸·Î ÀÎÇØ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ºñħ½ÀÀû Ç÷´çÃøÁ¤±â´Â ÀáÀçÀûÀÎ ÆíÀǼº ¶§¹®¿¡ ÁÖ¸ñÀ» ¹Þ°í ÀÖÁö¸¸, ½ºÆ®¸³Çü Ç÷´çÃøÁ¤±â´Â ÀÔÁõµÈ Á¤È®¼º, ½Å·Ú¼º ¹× È®°íÇÑ ½ÃÀå ÀÔÁö¸¦ ¹ÙÅÁÀ¸·Î ¿©ÀüÈ÷ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

Ç÷´çÃøÁ¤±â ½ÃÀå : Áö¿ªº° ºÐ¼®

ºÏ¹Ì´Â ³ôÀº ´ç´¢º´ À¯º´·ü°ú ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Ç÷´ç ÃøÁ¤±â ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ÀüÅëÀûÀÎ Ç÷´ç ÃøÁ¤±â¿Í ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ±â¼ú ¸ðµÎ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 Áß½ÉÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ÷´ÜÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î Çõ½ÅÀûÀÎ ´ç´¢º´ °ü¸® ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ÃßÀûÀ» Á¦°øÇÏ´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â±â ¹× ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ Á¢±Ù¼º ³ôÀº ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½Éµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Ç÷´ç ÃøÁ¤±â¿Í µðÁöÅÐ °Ç°­ Ç÷§Æû ¹× ¸ð¹ÙÀÏ ¾ÛÀ» ÅëÇÕÇÏ´Â Ãß¼¼µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áý¿¡¼­ ´ç´¢º´À» Ä¡·áÇϰíÀÚ ÇÏ´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ºÏ¹Ì¿¡¼­´Â ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹Ì±¹Àº ³ôÀº ´ç´¢º´ À¯º´·ü°ú ÷´ÜÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó·Î ÀÎÇØ Ç÷´ç ÃøÁ¤±â ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ Ç÷´ç ÃßÀûÀ» À§ÇÑ µðÁöÅÐ ÀÇ·á ¼Ö·ç¼Ç°ú ¸ð¹ÙÀÏ ¾Û ÅëÇÕÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âÁ¸ Ç÷´ç ÃøÁ¤±â¿Í ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛ ¸ðµÎ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Ç÷´ç ÃøÁ¤±â ½ÃÀå : °æÀï ±¸µµ

Abbott Laboratories, Roche Diagnostics, Medtronic µî ÁÖ¿ä ±â¾÷ÀÌ Ç÷´ç ÃøÁ¤±â ½ÃÀåÀ» ¼±µµÇϰí ÀÖÀ¸¸ç, Abbott´Â Çõ½ÅÀûÀÎ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛ¿¡ ÁßÁ¡À» µÐ Freestyle ºê·£µå·Î Àß ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. Accu-Chek ½Ã¸®Á º¸À¯ÇÑ Roche´Â °í±Þ ¹«¼± ¿¬°á°ú ¸ð¹ÙÀÏ ÅëÇÕ¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, Guardian ½Ã¸®Áî¿Í °°Àº Á¦Ç°À¸·Î CGMÀ» ¼±µµÇÏ´Â MedtronicÀº ¿Ïº®ÇÑ ´ç´¢º´ °ü¸® »ýŰ踦 Á¦°øÇÕ´Ï´Ù. ´Ù¸¥ ÁÖ¿ä ¾÷ü·Î´Â °íÁ¤¹Ð CGM ½Ã½ºÅÛÀ» Àü¹®À¸·Î ÇÏ´Â Dexcom, »ç¿ëÀÚ Ä£È­ÀûÀÎ OneTouch ±â±â·Î À¯¸íÇÑ LifeScan(Johnson & Johnson), Ascensia, Bayer, Omron Healthcare µîÀÌ ÀÖ½À´Ï´Ù. Trividia Health´Â TrueMetrix ºê·£µå·Î ÇÕ¸®ÀûÀÎ °¡°Ý´ëÀÇ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí, iHealth Labs´Â ½º¸¶Æ® Ç÷´ç ÃøÁ¤±â¿Í ¸ð¹ÙÀÏ ±â¼úÀ» ÅëÇÕÇÏ´Â µî Á¤È®¼º°ú »ç¿ë ÆíÀǼº¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ¾ÆÅ©·¹ÀÌ, »ç³ëÇÇ, ³ëº¸ ³ëµð½ºÅ©, À϶óÀÌ ¸±¸® µî Áß¼Ò±â¾÷Àº Á¦ÈÞ ¹× Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿¬°á¼º, Á¤È®¼º, µðÁöÅÐ Çコ ÅëÇÕÀÇ Çõ½Å¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ±Û·çÄÚ¹ÌÅÍÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå ±¸µµ

Á¦7Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : À¯Çüº°

Á¦8Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : ±â¼úº°

Á¦9Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : À¯Åë ä³Îº°

Á¦10Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ±Û·çÄÚ¹ÌÅÍ ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : ±Û·çÄÚ¹ÌÅÍ ¾÷°è

Á¦13Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Glucometer Market size was valued at US$ 16,435.12 Million in 2024, expanding at a CAGR of 12.8% from 2025 to 2032.

The glucometer market refers to the sector involved in the production and sale of devices used to measure blood glucose levels. These devices are crucial for individuals with diabetes to monitor and manage their condition. Glucometers typically consist of a portable device that reads blood samples from a fingerstick or other means. The market is driven by the increasing prevalence of diabetes worldwide, which requires regular monitoring for better management. Technological advancements, such as continuous glucose monitoring (CGM) systems, have expanded the market's scope. Key players in this space also focus on improving device accuracy, ease of use, and integration with mobile health platforms. The rising demand for home-based diabetes care solutions is further boosting the market. Additionally, growing awareness of diabetes prevention and management contributes to market growth.

Glucometer Market- Market Dynamics

Increasing adoption of mobile apps for real-time glucose tracking integration.

The increasing adoption of mobile apps for real-time glucose tracking is a key driver for the glucometer market. As smartphones and wearable technologies become more prevalent, many users now prefer glucometers that seamlessly integrate with mobile applications. These apps allow users to monitor their glucose levels in real-time, track trends, and share data with healthcare providers for better management of diabetes. This integration enhances user experience by providing instant feedback and helping individuals make informed decisions about their health. Additionally, the convenience of storing and analyzing glucose data on mobile devices encourages more consistent monitoring, which is crucial for effective diabetes management. The rise in digital health solutions is making it easier for consumers to manage their condition from home, further boosting the demand for glucometers with mobile app compatibility.

Glucometer Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2025-2032)

Based on Type segmentation, Blood Glucometer was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Strip-based Glucometer was the leading Technology in 2024

Based on region, North America was the leading revenue generator in 2024

Glucometer Market- Segmentation Analysis:

The Global Glucometer Market is segmented based on Type, Technology, Distribution, End-User, and Region.

The market is divided into three categories based on Type: Blood Glucometer, Continuous Glucose Monitoring (CGM) Systems. The Blood Glucometer segment is the most prominent in the glucometer market. This product type has been widely used for years, offering affordability, ease of use, and accessibility. Blood glucometers are especially popular in homecare settings, where users can easily monitor their glucose levels with minimal technical complexity. Despite the growth of continuous glucose monitoring (CGM) systems, blood glucometers remain dominant due to their lower cost, simple operation, and broad acceptance among individuals managing diabetes. The segment continues to be favored, particularly in regions with price-sensitive populations.

The market is divided into two categories based on Technology: Strip-based Glucometers, and Non-invasive Glucometers. The Strip-based Glucometer segment is the most prominent in the technology category. This technology has been widely used for glucose monitoring due to its simplicity and affordability. It operates by using a test strip that reacts with a blood sample, providing a reading of glucose levels. Strip-based glucometers are favored for their ease of use, quick results, and lower cost compared to other technologies. Although non-invasive glucometers are gaining attention for their potential convenience, strip-based glucometers remain dominant due to their proven accuracy, reliability, and established market presence.

Glucometer Market- Geographical Insights

North America holds a significant share of the glucometer market, driven by the high prevalence of diabetes and increasing awareness of diabetes management. The United States, in particular, plays a central role, with a growing demand for both traditional glucometers and continuous glucose monitoring (CGM) technologies. The region benefits from advanced healthcare infrastructure and favorable reimbursement policies, which support the adoption of innovative diabetes management solutions. There is also a rising focus on user-friendly devices that offer real-time data tracking, as well as affordable and accessible solutions. The increasing trend of integrating glucometers with digital health platforms and mobile apps is contributing to market growth. Additionally, as more individuals seek home-based diabetes care, demand for portable and easy-to-use monitoring devices continues to rise in North America.

The United States holds a dominant position in the glucometer market, driven by the high prevalence of diabetes and advanced healthcare infrastructure. The demand for both traditional glucometers and continuous glucose monitoring (CGM) systems is growing, with the increasing adoption of digital health solutions and mobile app integration for real-time glucose tracking.

Glucometer Market- Competitive Landscape:

The glucometer market is highly competitive, with key players such as Abbott Laboratories, Roche Diagnostics, and Medtronic leading the industry. Abbott is known for its Freestyle brand, focusing on innovative continuous glucose monitoring (CGM) systems. Roche, with its Accu-Chek range, emphasizes advanced wireless connectivity and mobile integration. Medtronic, a leader in CGM with products like the Guardian series, offers a complete diabetes care ecosystem. Other significant players include Dexcom, which specializes in high-accuracy CGM systems, and LifeScan (Johnson & Johnson), known for user-friendly OneTouch devices. Companies like Ascensia, Bayer, and Omron Healthcare focus on precision and ease of use. Trividia Health offers affordable solutions with its TrueMetrix brand, while iHealth Labs integrates smart glucometers with mobile technology. Smaller players, such as ARKRAY, Sanofi, Novo Nordisk, and Eli Lilly, are expanding their portfolios through collaborations and strategic partnerships. The market is driven by innovation in connectivity, accuracy, and digital health integration.

Recent Developments:

In September 2023, Abbott acquired Bigfoot, a key player in smart insulin management systems for diabetes. This strategic acquisition combined Abbott's expertise in continuous glucose monitoring with Bigfoot's advancements in insulin dosing support. The collaboration is expected to drive the development of connected solutions, enhancing the personalization and precision of diabetes care.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCOMETER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL GLUCOMETER MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOMETER MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOMETER MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOMETER MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL GLUCOMETER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Glucometer Market Overview

2. Executive Summary

3. Glucometer Key Market Trends

4. Glucometer Industry Study

5. Glucometer Market: Impact of Escalating Geopolitical Tensions

6. Glucometer Market Landscape

7. Glucometer Market - By Type

8. Glucometer Market - By Technology

9. Glucometer Market - By Distribution Channel

10. Glucometer Market - By End User

11. Glucometer Market- By Geography

12. Key Vendor Analysis- Glucometer Industry

13. 360 Degree AnalystView

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â